Home/Filings/4/0001062993-24-014289
4//SEC Filing

FRIEDBERG ALBERT 4

Accession 0001062993-24-014289

CIK 0001205922other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 4:05 PM ET

Size

21.0 KB

Accession

0001062993-24-014289

Insider Transaction Report

Form 4
Period: 2024-07-31
Transactions
  • Purchase

    Common Stock

    2024-07-31$5.74/sh+100,629$577,409663,044 total(indirect: By FCMI Parent Co.)
  • Purchase

    Common Stock

    2024-07-31$7.40/sh+16,128$119,283762,415 total(indirect: By FCMI Parent Co.)
  • Purchase

    Common Stock

    2024-07-31$6.41/sh+83,243$533,588746,287 total(indirect: By FCMI Parent Co.)
Holdings
  • Warrant (Right to Buy)

    (indirect: By FCMI Parent Co.)
    Exercise: $14.00From: 2024-02-08Exp: 2029-02-08Common Stock (118,226 underlying)
    118,226
  • Common Stock

    (indirect: By Pan Atlantic Holdings Ltd.)
    180
  • Common Stock

    (indirect: By Friedberg Global-Macro Hedge Fund Ltd.)
    16,724
  • Warrant (Right to Buy)

    (indirect: By FCMI Parent Co.)
    Exercise: $14.00From: 2023-10-03Exp: 2028-10-03Common Stock (214,285 underlying)
    214,285
  • Common Stock

    2,094
  • Warrant (Right to Buy)

    (indirect: By FCMI Parent Co.)
    Exercise: $7.64From: 2024-03-28Exp: 2029-03-28Common Stock (102,960 underlying)
    102,960
FRIEDBERG ALBERT
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2024-07-31$5.74/sh+100,629$577,409663,044 total(indirect: By FCMI Parent Co.)
  • Purchase

    Common Stock

    2024-07-31$7.40/sh+16,128$119,283762,415 total(indirect: By FCMI Parent Co.)
  • Purchase

    Common Stock

    2024-07-31$6.41/sh+83,243$533,588746,287 total(indirect: By FCMI Parent Co.)
Holdings
  • Warrant (Right to Buy)

    (indirect: By FCMI Parent Co.)
    Exercise: $14.00From: 2024-02-08Exp: 2029-02-08Common Stock (118,226 underlying)
    118,226
  • Warrant (Right to Buy)

    (indirect: By FCMI Parent Co.)
    Exercise: $7.64From: 2024-03-28Exp: 2029-03-28Common Stock (102,960 underlying)
    102,960
  • Warrant (Right to Buy)

    (indirect: By FCMI Parent Co.)
    Exercise: $14.00From: 2023-10-03Exp: 2028-10-03Common Stock (214,285 underlying)
    214,285
  • Common Stock

    (indirect: By Pan Atlantic Holdings Ltd.)
    180
  • Common Stock

    2,094
  • Common Stock

    (indirect: By Friedberg Global-Macro Hedge Fund Ltd.)
    16,724
Footnotes (6)
  • [F1]Mr. Friedberg is the majority owner of Pan Atlantic Holdings Ltd. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F2]Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F3]Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F4]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.10 to $6.10, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F5]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.11 to $7.06, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F6]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.18 to $7.40, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

VACCINEX, INC.

CIK 0001205922

Entity typeother

Related Parties

1
  • filerCIK 0001268239

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:05 PM ET
Size
21.0 KB